Analyst says sell Abbott after stock 'Overreacted' to COVID-19 opportunity
June 01, 2020 at 15:04 PM EDT
Goldman says competitors have steadily diminished Abbott's early advantage with their own approvals.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|